|
| Primary information |
|---|
| ID | 15494 |
| Therapeutic ID | Th1602 |
| Protein Name | Albumin Aggregated |
| Sequence | NA
|
| Molecular Weight | NA |
| Chemical Formula | NA |
| Isoelectric Point | NA |
| Hydrophobicity | NA |
| Melting point | NA |
| Half-life | NA |
| Description | Albumin aggregated is an ingredient in the DRAXIMAGE MAA kit for the preparation of technetium tc99m albumin aggregated injection.[L12816] This imaging agent is used to assess lung perfusion and for the evaluation of peritoneovenous (LeVeen) shunt patency. |
| Indication/Disease | Albumin aggregated is an ingredient in the DRAXIMAGE MAA kit for the preparation of technetium tc99m albumin aggregated injection, which is indicated for the assessment of lung perfusion and for the evaluation of peritoneovenous (LeVeen) shunt patency.[L12816] |
| Pharmacodynamics | NA |
| Mechanism of Action | NA |
| Toxicity | NA |
| Metabolism | NA |
| Absorption | NA |
| NA |
| Clearance | NA |
| Categories | Radioactive Diagnostic Agent |
| Patents Number | NA |
| Date of Issue | NA |
| Date of Expiry | NA |
| Drug Interaction | NA |
| Target | NA |
| Brand Name | Draximage Maa |
| Company | Jubilant DraxImage Inc., dba Jubilant Radiopharma |
| Brand Description | Jubilant DraxImage Inc., dba Jubilant Radiopharma |
| Prescribed For | Intravenous |
| Chemical Name | 2.5 mg/1 |
| Formulation | NA |
| Physical Appearance | Instances of hemodynamic or idiosyncratic reactions to preparations of Technetium Tc 99m Albumin Aggregated have been reported |
| Route of Administration | The kit consists of reaction vials which contain the sterile, non-pyrogenic, non-radioactive ingredients necessary to produce Technetium Tc 99m Albumin Aggregated Injection for diagnostic use by intravenous injection. |
| Recommended Dosage | Technetium Tc 99m Albumin Aggregated Injection is a lung imaging agent which may be used as an adjunct in the evaluation of pulmonary perfusion in adults and pediatric patients. |
| Contraindication | NA |
| Side Effects | NA |
| Useful Link 1 | Link |
| Useful Link 2 | Link |
| Remarks | NA |